FDA Inspection 649637 — AbbVie Deutschland GmbH & Co. KG

AbbVie Deutschland GmbH & Co. KG — FEI 3002807401

The FDA completed an inspection of AbbVie Deutschland GmbH & Co. KG on December 17, 2009 in Ludwigshafen. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 17, 2009
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ludwigshafen (Germany)